Loading...

Link Pharma Chem

BSE:524748
Snowflake Description

Flawless balance sheet and undervalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
524748
BSE
₹97M
Market Cap
  1. Home
  2. IN
  3. Materials
Company description

Link Pharma Chem Limited manufactures and sells organic intermediates for pharmaceutical, agro, and specialty chemicals industries in India and internationally. The last earnings update was 117 days ago. More info.


Add to Portfolio Compare Print
524748 Share Price and Events
7 Day Returns
5.8%
BSE:524748
5%
IN Chemicals
4.1%
IN Market
1 Year Returns
-36.8%
BSE:524748
1.1%
IN Chemicals
0.1%
IN Market
524748 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Link Pharma Chem (524748) 5.8% 4.5% 4.5% -36.8% 191.9% 207.4%
IN Chemicals 5% 0.4% 8.5% 1.1% 54.5% 170.6%
IN Market 4.1% -0.5% 7.6% 0.1% 35.2% 47.8%
1 Year Return vs Industry and Market
  • 524748 underperformed the Chemicals industry which returned 1.1% over the past year.
  • 524748 underperformed the Market in India which returned 0.1% over the past year.
Price Volatility
524748
Industry
5yr Volatility vs Market
Related Companies

524748 Value

 Is Link Pharma Chem undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Link Pharma Chem to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Link Pharma Chem.

BSE:524748 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 16%
Perpetual Growth Rate 10-Year IN Government Bond Rate 7.6%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for BSE:524748
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year IN Govt Bond Rate 7.6%
Equity Risk Premium S&P Global 8.6%
Chemicals Unlevered Beta Simply Wall St/ S&P Global 0.87
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.865 (1 + (1- 35%) (20.67%))
0.988
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.99
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 7.55% + (0.988 * 8.6%)
16.04%

Discounted Cash Flow Calculation for BSE:524748 using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Link Pharma Chem is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

BSE:524748 DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (INR, Millions) Source Present Value
Discounted (@ 16.04%)
2019 20.34 Est @ 11.69% 17.53
2020 22.47 Est @ 10.45% 16.68
2021 24.62 Est @ 9.58% 15.75
2022 26.83 Est @ 8.97% 14.79
2023 29.12 Est @ 8.54% 13.84
2024 31.52 Est @ 8.25% 12.91
2025 34.05 Est @ 8.04% 12.02
2026 36.74 Est @ 7.89% 11.17
2027 39.60 Est @ 7.79% 10.38
2028 42.66 Est @ 7.72% 9.63
Present value of next 10 years cash flows ₹134.70
BSE:524748 DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= ₹42.66 × (1 + 7.55%) ÷ (16.04% – 7.55%)
₹540.10
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= ₹540.10 ÷ (1 + 16.04%)10
₹121.96
BSE:524748 Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= ₹134.70 + ₹121.96
₹256.66
Equity Value per Share
(INR)
= Total value / Shares Outstanding
= ₹256.66 / 4.44
₹57.8
BSE:524748 Discount to Share Price
Calculation Result
Value per share (INR) From above. ₹57.80
Current discount Discount to share price of ₹21.95
= -1 x (₹21.95 - ₹57.80) / ₹57.80
62%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Link Pharma Chem is available for.
Intrinsic value
>50%
Share price is ₹21.95 vs Future cash flow value of ₹57.8
Current Discount Checks
For Link Pharma Chem to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Link Pharma Chem's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Link Pharma Chem's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Link Pharma Chem's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Link Pharma Chem's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BSE:524748 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in INR ₹2.96
BSE:524748 Share Price ** BSE (2019-05-24) in INR ₹21.95
India Chemicals Industry PE Ratio Median Figure of 232 Publicly-Listed Chemicals Companies 14.78x
India Market PE Ratio Median Figure of 2,781 Publicly-Listed Companies 15.78x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Link Pharma Chem.

BSE:524748 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= BSE:524748 Share Price ÷ EPS (both in INR)

= 21.95 ÷ 2.96

7.41x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Link Pharma Chem is good value based on earnings compared to the IN Chemicals industry average.
  • Link Pharma Chem is good value based on earnings compared to the India market.
Price based on expected Growth
Does Link Pharma Chem's expected growth come at a high price?
Raw Data
BSE:524748 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 7.41x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
13.5%per year
India Chemicals Industry PEG Ratio Median Figure of 50 Publicly-Listed Chemicals Companies 1.42x
India Market PEG Ratio Median Figure of 559 Publicly-Listed Companies 1.34x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Link Pharma Chem, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Link Pharma Chem's assets?
Raw Data
BSE:524748 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in INR ₹25.42
BSE:524748 Share Price * BSE (2019-05-24) in INR ₹21.95
India Chemicals Industry PB Ratio Median Figure of 268 Publicly-Listed Chemicals Companies 1.42x
India Market PB Ratio Median Figure of 3,644 Publicly-Listed Companies 1.06x
BSE:524748 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= BSE:524748 Share Price ÷ Book Value per Share (both in INR)

= 21.95 ÷ 25.42

0.86x

* Primary Listing of Link Pharma Chem.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Link Pharma Chem is good value based on assets compared to the IN Chemicals industry average.
X
Value checks
We assess Link Pharma Chem's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check)
  5. Link Pharma Chem has a total score of 5/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

524748 Future Performance

 How is Link Pharma Chem expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Link Pharma Chem, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
13.5%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Link Pharma Chem expected to grow at an attractive rate?
  • Link Pharma Chem's earnings growth is expected to exceed the low risk savings rate of 7.6%.
Growth vs Market Checks
  • Link Pharma Chem's earnings growth is positive but not above the India market average.
  • Unable to compare Link Pharma Chem's revenue growth to the India market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
BSE:524748 Future Growth Rates Data Sources
Data Point Source Value (per year)
BSE:524748 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 13.5%
India Chemicals Industry Earnings Growth Rate Market Cap Weighted Average 18.4%
India Chemicals Industry Revenue Growth Rate Market Cap Weighted Average 13.5%
India Market Earnings Growth Rate Market Cap Weighted Average 16.9%
India Market Revenue Growth Rate Market Cap Weighted Average 10.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BSE:524748 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in INR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BSE:524748 Past Financials Data
Date (Data in INR Millions) Revenue Cash Flow Net Income *
2018-12-31 251 13
2018-09-30 253 14
2018-06-30 228 11
2018-03-31 236 35 11
2017-12-31 221 11
2017-09-30 213 5
2017-06-30 181 4
2017-03-31 161 22 2
2016-12-31 160 19
2016-09-30 149 6
2016-06-30 130 5
2016-03-31 123 -39 6

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Link Pharma Chem's earnings are expected to grow by 13.5% yearly, however this is not considered high growth (20% yearly).
  • Unable to determine if Link Pharma Chem is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BSE:524748 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Link Pharma Chem Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BSE:524748 Past Financials Data
Date (Data in INR Millions) EPS *
2018-12-31 2.96
2018-09-30 3.15
2018-06-30 2.58
2018-03-31 2.56
2017-12-31 2.37
2017-09-30 1.12
2017-06-30 0.86
2017-03-31 0.51
2016-12-31
2016-09-30 1.39
2016-06-30 1.20
2016-03-31 1.33

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Link Pharma Chem will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Link Pharma Chem's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the India market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the India market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Link Pharma Chem has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

524748 Past Performance

  How has Link Pharma Chem performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Link Pharma Chem's growth in the last year to its industry (Chemicals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Link Pharma Chem has delivered over 20% year on year earnings growth in the past 5 years.
  • Link Pharma Chem's 1-year earnings growth is less than its 5-year average (21.2% vs 50.6%)
  • Link Pharma Chem's earnings growth has exceeded the IN Chemicals industry average in the past year (21.2% vs 15.4%).
Earnings and Revenue History
Link Pharma Chem's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Link Pharma Chem Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BSE:524748 Past Revenue, Cash Flow and Net Income Data
Date (Data in INR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 250.79 12.75 50.42
2018-09-30 252.90 13.64 53.52
2018-06-30 228.13 11.44 51.47
2018-03-31 235.76 11.35 50.50
2017-12-31 220.69 10.52 43.19
2017-09-30 212.59 4.97 38.28
2017-06-30 180.73 3.82 37.05
2017-03-31 161.47 2.27 36.68
2016-12-31 159.67 19.49 35.46
2016-09-30 148.75 6.12 34.58
2016-06-30 129.90 5.34 33.73
2016-03-31 123.44 5.92 33.99
2015-12-31 117.03 -15.15 37.45
2015-09-30 153.24 -4.32 39.39
2015-06-30 201.60 -11.34 33.35
2015-03-31 177.11 -21.96 33.44
2014-12-31 188.79 -18.47 40.27
2014-09-30 205.05 -14.14 38.87
2014-06-30 226.28 -5.16 29.23
2014-03-31 238.28 5.17 36.86
2013-12-31 225.22 2.12 34.79
2013-09-30 189.30 2.19 34.72
2013-06-30 175.63 2.45 34.72
2013-03-31 164.69 2.88 34.41
2012-12-31 176.34 7.95 31.79
2012-09-30 186.71 7.49 31.06
2012-06-30 186.66 5.70 30.87

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Link Pharma Chem has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Link Pharma Chem used its assets more efficiently than the IN Chemicals industry average last year based on Return on Assets.
  • Link Pharma Chem has become profitable over the past 3 years. This is considered to be a significant improvement in its use of capital (Return on Capital Employed).
X
Past performance checks
We assess Link Pharma Chem's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Link Pharma Chem has a total score of 4/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

524748 Health

 How is Link Pharma Chem's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Link Pharma Chem's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Link Pharma Chem is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Link Pharma Chem's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Link Pharma Chem's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 4.7x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Link Pharma Chem Company Filings, last reported 4 months ago.

BSE:524748 Past Debt and Equity Data
Date (Data in INR Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 105.41 20.15 5.45
2018-09-30 105.41 20.15 5.45
2018-06-30 97.90 27.11 2.02
2018-03-31 97.90 27.11 2.02
2017-12-31 97.01 35.94 1.17
2017-09-30 97.01 35.94 1.17
2017-06-30 92.51 44.96 5.95
2017-03-31 86.03 47.30 1.99
2016-12-31 92.03 45.79 19.64
2016-09-30 92.03 45.79 19.64
2016-06-30 89.60 50.78 8.53
2016-03-31 89.60 54.08 2.72
2015-12-31 85.92 53.00 5.31
2015-09-30 85.92 53.00 5.31
2015-06-30 83.68 99.20 15.01
2015-03-31 83.68 108.01 12.07
2014-12-31 91.27 85.90 0.78
2014-09-30 91.27 85.90 0.78
2014-06-30 106.67 90.78 0.76
2014-03-31 106.67 90.78 2.20
2013-12-31 105.41 80.41 1.50
2013-09-30 105.41 80.41 1.50
2013-06-30 101.50 89.39 1.87
2013-03-31 101.50 89.39 1.87
2012-12-31
2012-09-30 103.22 68.20 0.76
2012-06-30 98.62 72.99 1.16
  • Link Pharma Chem's level of debt (19.1%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (76.4% vs 19.1% today).
  • Debt is well covered by operating cash flow (175.8%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 4.4x coverage).
X
Financial health checks
We assess Link Pharma Chem's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Link Pharma Chem has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

524748 Dividends

 What is Link Pharma Chem's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Link Pharma Chem dividends.
If you bought ₹2,000 of Link Pharma Chem shares you are expected to receive ₹0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Link Pharma Chem's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Link Pharma Chem's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BSE:524748 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
India Chemicals Industry Average Dividend Yield Market Cap Weighted Average of 165 Stocks 1%
India Market Average Dividend Yield Market Cap Weighted Average of 1407 Stocks 1.4%
India Minimum Threshold Dividend Yield 10th Percentile 0.3%
India Bottom 25% Dividend Yield 25th Percentile 0.5%
India Top 25% Dividend Yield 75th Percentile 2%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Link Pharma Chem has not reported any payouts.
  • Unable to verify if Link Pharma Chem's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Link Pharma Chem's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Link Pharma Chem has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Link Pharma Chem's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Link Pharma Chem afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Link Pharma Chem has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

524748 Management

 What is the CEO of Link Pharma Chem's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Satish Thakur
COMPENSATION ₹3,921,000
AGE 67
TENURE AS CEO 9.8 years
CEO Bio

Mr. Satish G. Thakur has been Managing Director of Link Pharma Chem Ltd. since July 2009 and has been its Executive Director since December 28, 1984. Mr. Thakur holds rich experience of Company Management. He is Licenciate of Technical Chemistry.

CEO Compensation
  • Satish's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Satish's remuneration is higher than average for companies of similar size in India.
Management Team Tenure

Average tenure of the Link Pharma Chem management team in years:

3.7
Average Tenure
  • The tenure for the Link Pharma Chem management team is about average.
Management Team

Balvant Retarekar

TITLE
Executive Chairman
COMPENSATION
₹4M
AGE
63

Satish Thakur

TITLE
MD & Executive Director
COMPENSATION
₹4M
AGE
67
TENURE
9.8 yrs

Ravindra Bedekar

TITLE
Chief Financial Officer
COMPENSATION
₹293K
TENURE
3.7 yrs

Bhushan Joshi

TITLE
Compliance Officer & Company Secretary
COMPENSATION
₹217K
TENURE
3.7 yrs
Board of Directors Tenure

Average tenure and age of the Link Pharma Chem board of directors in years:

7.8
Average Tenure
64.5
Average Age
  • The tenure for the Link Pharma Chem board of directors is about average.
Board of Directors

Balvant Retarekar

TITLE
Executive Chairman
COMPENSATION
₹4M
AGE
63

Satish Thakur

TITLE
MD & Executive Director
COMPENSATION
₹4M
AGE
67
TENURE
34.4 yrs

Suresh Dhatrak

TITLE
Independent Director
COMPENSATION
₹30K
AGE
66

Devang Shah

TITLE
Independent Director
COMPENSATION
₹30K
TENURE
7.8 yrs

Sayali Sohoni

TITLE
Independent Woman Director
COMPENSATION
₹30K
AGE
30
TENURE
4.2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (₹) Value (₹)
X
Management checks
We assess Link Pharma Chem's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Link Pharma Chem has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

524748 News

Simply Wall St News

524748 Company Info

Description

Link Pharma Chem Limited manufactures and sells organic intermediates for pharmaceutical, agro, and specialty chemicals industries in India and internationally. The company was incorporated in 1984 and is based in Vadodara, India.

Details
Name: Link Pharma Chem Limited
524748
Exchange: BSE
Founded: 1984
₹97,470,467
4,440,568
Website: http://www.linkpharmachem.co.in
Address: Link Pharma Chem Limited
504 Centre Point,
R.C.Dutt Road,
Vadodara,
Gujarat, 390005,
India
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
BSE 524748 Equity Shares Mumbai Stock Exchange IN INR 11. Oct 1996
Number of employees
Current staff
Staff numbers
88
Link Pharma Chem employees.
Industry
Commodity Chemicals
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/25 12:34
End of day share price update: 2019/05/24 00:00
Last earnings filing: 2019/01/28
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.